The burden of quality verification falls entirely on the buyer
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
How to Fly with GLP-1s One of the biggest concerns I've heard is how to get through airport security with GLP-1 injector pens or vials
At microdose levels, you are drawing from the vial infrequently enough that losing track of the date is a real risk
If you're still losing, it's working
Participants taking the highest dose of retatrutide saw, on average, the following health improvements: these average reductions in cardiovascular disease risk factors: 37 percent reduction in triglycerides, or fats in the blood 16.5 percent reduction in non-HDL bad cholesterol 9.3 mmHg reduction in systolic blood pressure, the pressure in the arteries when the heart beats 7.5-inch reduction in waist circumference 51.2 percent reduction in high-sensitivity C-reactive protein, a measurement of inflammation in the body Side Effects Led More Than 1 in 10 Participants to Drop Out Side-effect rates differed between the two trials